1. The document provides an overview of four patient cases presenting with palpitations. It reviews the approach to evaluating patients with palpitations, including obtaining a history, ECG, Holter monitor or event monitor depending on symptom frequency.
2. For Case 1, a Holter monitor showed ventricular tachycardia, indicating a need for an ICD. Case 2's Holter demonstrated SVT, leading to ablation. Case 3's normal Holter did not explain symptoms but an event monitor was ordered due to underlying cardiomyopathy. Case 4 required further workup.
3. The document emphasizes correlating rhythms to symptoms to make a diagnosis, and considering risk of malignant arrhythmias to guide management.
Isolated Cerebellar Stroke Masquerades as DepressionZahiruddin Othman
There are numerous reports on neurological conditions masquerading as psychiatric disorders. However, cerebellar
stroke is not established as one of it. The 2 case reports will highlight that this masquerade is possible and the physician's
high index of suspicion is the key to accurate diagnosis.
Isolated Cerebellar Stroke Masquerades as DepressionZahiruddin Othman
There are numerous reports on neurological conditions masquerading as psychiatric disorders. However, cerebellar
stroke is not established as one of it. The 2 case reports will highlight that this masquerade is possible and the physician's
high index of suspicion is the key to accurate diagnosis.
It is very common to see patients with different Tachycardias in Emergency department. Dealing with tachycardias as a part of ACLS is a must to know for all Emergency Physicians. This presentation covers different types of Tachycardias like Sinus Tachycardia, stable tachycardia, unstable tachycardia, ventricular tachycardia, supraventricular tachycardia, svt with abberancy, AIVR, TCA Toxicity, Ventricular paced rhythm, modified vagal maneuvre, atrial fibrillation and others
It is very common to see patients with different Tachycardias in Emergency department. Dealing with tachycardias as a part of ACLS is a must to know for all Emergency Physicians. This presentation covers different types of Tachycardias like Sinus Tachycardia, stable tachycardia, unstable tachycardia, ventricular tachycardia, supraventricular tachycardia, svt with abberancy, AIVR, TCA Toxicity, Ventricular paced rhythm, modified vagal maneuvre, atrial fibrillation and others
palpitation is one of the most presentations in outpatients, about 16% of patients presenting to ER complaining from palpitation , for the juniors , my presentation aiming to help them to how to approach with a case complaining of palpitation
Interactive Cases in Clinical Medicine (SPHMMC production) Episode 01ahmedx20
An interactive case where we discuss the diagnosis and management of Acute Rheumatic Fever, Rheumatic Heart Disease and Heart Failure in general.
Presented at Saint Paul's Hospital Millennium Medical College (SPHMMC), Addis Ababa, Ethiopia
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Acute scrotum is a general term referring to an emergency condition affecting the contents or the wall of the scrotum.
There are a number of conditions that present acutely, predominantly with pain and/or swelling
A careful and detailed history and examination, and in some cases, investigations allow differentiation between these diagnoses. A prompt diagnosis is essential as the patient may require urgent surgical intervention
Testicular torsion refers to twisting of the spermatic cord, causing ischaemia of the testicle.
Testicular torsion results from inadequate fixation of the testis to the tunica vaginalis producing ischemia from reduced arterial inflow and venous outflow obstruction.
The prevalence of testicular torsion in adult patients hospitalized with acute scrotal pain is approximately 25 to 50 percent
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Sun 1040-holters-101- -park
1. 5/25/14
1
Palpitations and Holters 101
A quick review in 25 minutes for the Family Physician
Jonathan Tang
UBC Division of Cardiology
BCCFP 2014 Spring Family Medicine Conference
June 8, 2014
Disclosures
Relationships with commercial interests:
Received financial support:
In-kind support:
Conflict of interest:
2. 5/25/14
2
Objectives
1. To develop an approach to the care of
patients with palpitations
2. To become familiar with the Holter report
Case 1. The case of Willy Maykit.
You see Mr. Maykit, a 70 year old chap, in your office.
He is a gentleman with known ischaemic cardiomyopathy,
with a 4-vessel CABG 5 years ago, and an LVEF 40%.
He comes to your office today because he had sudden onset
of “heart racing” in his chest, which was associated with
lightheadedness, and after a minute, he lost consiousness.
He came to after a few minutes, and is now back to
normal.
This has occurred once before, about 6 months ago.
3. 5/25/14
3
Case 2. The case of Tak Ekardya.
You see Mr. Ekardya, a 28 year old chap, in your office.
He is an otherwise well young athletic individual, who has
noted palpitations over the last 6 months.
What he notes is that every 10 weeks or so, he will have,
with utter randomness, a feeling of “rapid heart
beating”, associated with lightheadedness, but without
ever having had loss of consiousness. This will last 10
minutes, and just as abruptly as it started, it will stop.
Case 3. The case of Earl E. deMyse.
You see Mr. deMyse, a 58 year old chap, in your office.
He came to the attention of cardiologists 3 years ago, when
he underwent an ECG for insurance purposes
demonstrating LVH. A subsequent echocardiogram and
cardiac MRI demonstrated findings consistent with
hypertrophic cardiomyopathy.
He now has symptoms of “heart pounding hard”, which
occurs once every 3 weeks or so, lasts a few seconds at
most, and is not associated with lightheadedness or
chest pain. He has never had syncope.
4. 5/25/14
4
Case 4. The case of Terry Fyde.
You see Miss Fyde, a 26 year old, in your office.
She is an otherwise healthy lady who comes to your
attention after having had a syncopal spell.
On this occasion, she was at work at the counter of her
university library. She had missed her lunch and the
room was full of students. She felt unwell,
lightheaded, and after a few minutes, proceeded to go
to get a drink of water but lost consciousness at the
water cooler.
This type of scenario has occurred a few times before,
and she has lost consciousness all times, thankfully
without much more than a bruised ego.
Her ECG is normal.
Palpitations - the second most common cardiac symptom
5. 5/25/14
5
Definition
an awareness of heart beat
a disagreeable sensation of pulsation in the chest and/
or adjacent areas
rapid fluttering, irregular
“flip flop”
sudden pause - then a “boom”
rapid, regular, fluttering
associated with neck pounding
sudden on/off “like a switch”
Palpitations - historical features
Substrate risk:
• known structural or ischaemic heart disease
hypertension, valvular heart disease, previous MI, decreased EF,
congenital heart disease, hypertrophic cardiomyopathy, etc.
• known electrical substrate
Wolff-Parkinson-White, prolonged QT, Brugada, etc.
• family history of possible inherited heart disease
hypertrophic cardiomyopathy, long QT syndrome, Brugada, ARVC, dilated
cardiomyopathy, Fabry’s, unexplained sudden cardiac death in young
family member, etc.
Important features to establish
6. 5/25/14
6
Palpitations - historical features
Characteristics of palpitations:
regularity, rate, onset and termination
triggers (ie. exercise) and aggravating/alleviating factors
Burden of symptoms
• frequency and duration of symptoms
• other associated symptoms (ie. chest pain, nausea, sweating, etc.)
• haemodynamic impairment (syncope or pre-syncope)
Important features to establish
What is your next step?
a. Get an ECG
b. Get a Holter
c. Send him to ER
d. Tell him to get a will
Case 1. The case of Willy Maykit.
You see Mr. Maykit, a 70 year old chap, in your office.
He is a gentleman with known ischaemic cardiomyopathy, with a 4-vessel
CABG 5 years ago, and an LVEF 40%.
He comes to your office today because he had sudden onset of “heart racing”
in his chest, which was associated with lightheadedness, and after a minute, he
lost consiousness. He came to after a few minutes, and is now back to
normal.
This has occurred once before, about 6 months ago.
7. 5/25/14
7
Why do we worry about palpitations?
The management strategy depends on:
• the suspected arrhythmic diagnosis
• the ability to obtain definitive ECG diagnosis
• the risk of a malignant arrhythmia
• the impairment in quality of life
Manifestations of possible death
What is the cause of his syncope?
a.Ventricular tachycardia
b. Can’t be sure
c. SVT
d. Vasovagal (from pretty GP)
Case 1. The case of Willy Maykit.
Mr. Maykit is seen in the Emergency. His ECG demonstrates sinus rhythm with
a prior inferior infarct. He is admitted to a monitored bed.
He is asymptomatic and reading his book, when the telemetry alarm bells go
off. The strip shows the following:
8. 5/25/14
8
Diagnosis: the need for rhythm-symptom correlation
The only means to achieve a definitive diagnosis
behind a patient’s symptoms is to obtain an ECG at
the time of palpitations.
However, in the absence of a diagnosis, one can infer
the likely cause of symptoms, and the risk associated
with the suspected arrhythmia.
Risk: what to look for on monitoring
the word “normal”
narrow-complex
not too fast
short
infrequent
wide-complex
fast
sustained
frequent
associated with syncope
THE BAD
9. 5/25/14
9
Diagnosis: what method to choose?
HOLTER
IMPLANTABLE
LOOP
RECORDER
Easily available
Limited duration
(24 - 48 hrs)
Useful for frequent
symptoms
Diagnostic yield:
up to 10%
EVENT/LOOP
RECORDER
Longer duration
(1 to 4 weeks)
Useful for less
frequent symptoms
Needs patient self-
activation
Diagnostic yield:
25%
Longest duration
(up to 3 years)
For infrequent but
debilitating symptoms
with suspected cardiac
cause
Diagnostic yield:
70%
Case 1. The case of Willy Maykit.
Mr. Maykit was referred to a cardiologist for further
management for his high-risk palpitations/syncope
with ventricular tachycardia suspected to be the
underlying cause.
A dual-chamber ICD was placed.
10. 5/25/14
10
What is your next step?
a. Get an ECG
b. Get a Holter
c. Get an event monitor
d. Tell him to stop whining
Case 2. The case of Tak Ekardya.
You see Mr. Ekardya, a 28 year old chap, in your office.
He is an otherwise well young athletic individual, who has noted palpitations
over the last 6 months.
What he notes is that every 10 weeks or so, he will have, with utter
randomness, a feeling of “rapid heart beating”, associated with lightheadedness,
but without ever having had loss of consiousness. This will last 10 minutes, and
just as abruptly as it started, it will stop.
Case 2. The case of Tak Ekardya.
His ECG is interpreted as normal.
You are cognizant that it will be difficult to obtain a
diagnosis for this gentleman as his symptoms are
relatively short and infrequent.
While a diagnosis is not possible at this time, with a normal
history, examination, and ECG, you attempt to reassure
him that his symptoms do not confer any high-risk
features. You give him instructions to seek medical
attention and get an ECG if his symptoms become
protracted.
He looks at you with a doubtful face, but duly states that he
will do as instructed.
11. 5/25/14
11
Case 2. The case of Tak Ekardya.
You see him back in the office after 3 months.
He tells you know that with his examinations, his
symptoms are occurring longer and more frequently
(once every few days, 30 minutes each time now). You
note that he is drinking more coffee as well.
You arrange for a Holter monitor.
12. 5/25/14
12
Case 2. The case of Tak Ekardya.
HOLTER REPORT
NAME: TAK EKARDYA
DOB: 04/31/1986
REPORT:
Predominant sinus rhythm with frequent PACs
Runs of regular, narrow complex, long RP tachycardia, possible atypical AVNRT or atrial
tachycardia; longest run 551 beats at 185 bpm
Symptoms of “palpitations” correlated with runs of SVT
IMPRESSION:
Symptomatic SVT; long RP tachycardia, atypical AVNRT or atrial tachycardia
HOLTER MONITOR PATIENT DIARY
TIME ACTIVITY SYMPTOMS TIME ACTIVITY SYMPTOMS
0920 Eating
0950 Watching TV
1000 Bathroom
1030 Driving to work
1055 Meeting
1100 Sitting at desk
1130 Coffee
1200 Lunch
1300 Angry
1320 Feel better
1350 Coffee
1500 Email
1600 Leaving work
1730 In accident
1750 Bathroom
1800 Making dinner
1850 Sitting
1910 Bus to friends
1920 Watching TV
2000 Chatting
2100 Talking to mom
2200 Going to sleep
0800 Breakfast
0900 Return Holter
None
None
None
None
Pounding heart
“Blip”
Heart racing
None
Heart racing
None
Heart racing
Tired
Happy
Chest pain
None
None
None
None
None
None
None
None
None
13. 5/25/14
13
Going through a Holter report
HOLTER REPORT
NAME: TAK EKARDYA
DOB: 04/31/1986
REPORT:
Predominant sinus rhythm with frequent PACs
Runs of regular, narrow complex, long RP tachycardia, possible atypical AVNRT or atrial
tachycardia; longest run 551 beats at 185 bpm
Symptoms of “palpitations” correlated with runs of SVT
IMPRESSION:
Symptomatic SVT; long RP tachycardia, atypical AVNRT or atrial tachycardia
NAME
HEART RATES
TYPES OF ECTOPICS
SUBDIVISIONS OF ECTOPY
Isolated, Couplets, Runs, Duration, Rate
REPORT
Predominant sinus rhythm with frequent PACs
Runs of regular, narrow complex, long RP tachycardia, possible atypical AVNRT or atrial
tachycardia; longest run 551 beats at 185 bpm
Symptoms of “palpitations” correlated with runs of SVT
IMPRESSION:
Symptomatic SVT; long RP tachycardia, atypical AVNRT or atrial tachycardia
Bare facts:
Diagnostic Holter with rhythm symptom
correlation
Diagnosis: SVT
Non-lethal
Significant impairment in quality of life
Case 2. The case of Tak Ekardya.
Mr. Ekardya’s Holter report was reviewed.
He was reassured that his new diagnosis of SVT was not
life-threatening.
The possible management options were discussed. Given
that he had significant impairment in quality of life, a
referral was made for him to undergo an
electrophysiology study and ablation.
He underwent ablation for AVNRT and has not had any
further episodes since.
14. 5/25/14
14
What is your next step?
a. Get an ECG
b. Get a Holter
c. Get an event monitor
d. Send him to a cardiologist
Case 3. The case of Earl E. deMyse.
You see Mr. deMyse, a 58 year old chap, in your office.
He came to the attention of cardiologists 3 years ago, when he underwent an
ECG for insurance purposes demonstrating LVH. A subsequent echocardiogram
and cardiac MRI demonstrated findings consistent with hypertrophic
cardiomyopathy.
He now has symptoms of “heart pounding hard”, which occurs once every 3
weeks or so, lasts a few seconds at most, and is not associated with
lightheadedness or chest pain. He has never had syncope.
Patients with hypertrophic cardiomyopathy are at
increased risk of sudden cardiac death
Therefore, suspicion of any possible arrhythmic symptoms
should come to the attention of a cardiologist
The cardiologist reviews Mr. deMyse and feels that on
history and review of his recent tests, there are no high risk
features to suggest a further increased risk of a ventricular
arrhythmia.
However, to further delineate his risk, Mr. deMyse undergoes
a Holter.
Case 3. The case of Earl E. deMyse.
15. 5/25/14
15
Case 3. The case of Earl E. deMyse.
HOLTER REPORT
NAME: EARL DEMYSE
DOB: 13/30/1956
REPORT:
Sinus rhythm throughout
Only one PAC noted
No arrhythmias. No symptoms noted.
IMPRESSION:
Normal Holter
Bare facts:
This is a reassuring Holter (ie. favourable prognosis)
He is still at increased risk of sudden cardiac death
given his known diagnosis of hypertrophic
cardiomyopathy
However, there are no high-risk features to suggest
that he is at further increased risk
We still don’t know the actual etiology behind his
“heart pounding” given the lack of rhythm-symptom
correlation
In patients with hypertrophic cardiomyopathy, the
presence of nonsustained ventricular tachycardia, even
if asymptomatic, would be considered to be a feature
of increased risk for sudden cardiac death
The cardiologist reviews Mr. deMyse again. He is still
concerned that his “heart pounding” could still represent a
ventricular dysrhythmia (ie. PVC).
He arranges for an event monitor.
Before the event monitor is arranged, Mr. deMyse notes
that he is under more financial stress and that he is now
having these “heart pounding” almost daily. Therefore, his
cardiologist arranges for a Holter.
Case 3. The case of Earl E. deMyse.
16. 5/25/14
16
Case 3. The case of Earl E. deMyse.
HOLTER REPORT
NAME: EARL DEMYSE
DOB: 13/30/1956
REPORT:
Sinus rhythm throughout
Frequent, isolated PVCs. No runs.
Symptoms of “heart pounding” corresponded to sinus rhythm
IMPRESSION:
Sinus rhythm with frequent PVCs. No rhythm symptom correlation.
PVCs: what to do about them?
In the presence of a reassuring history and physical
examination, normal ECG, and normal cardiac
structure, PVCs are considered to be benign.
That means:
• reassuring history:
• no family history of sudden cardiac death
• no genetic predisposition (ie. no family history of hypertrophic
cardiomyopathy, Brugada, etc.)
• no history to suggest angina or syncope
• normal physical examination:
• normal ECG:
• no evidence of WPW, LVH, long QT, Brugada, etc.
• normal echocardiogram:
• no significant ventricular or valvular disease
17. 5/25/14
17
PVC-induced cardiomyopathy: a new entity
Do the number of PVCs matter?
“PVC-induced cardiomyopathy” as a diagnosis is still a new
entity in its infancy and more is still yet to be known
The higher the PVC burden, the further the risk of
depressed EF
PVCs: in a nutshell
1. PVCs are extremely common, and in the majority of cases,
considered to be benign.
2. In the setting of isolated PVCs without sinister findings (on history,
examination, and ECG), all that is needed is reassurance.
3. In the setting of suspected frequent PVCs, then in addition to the
history, examination, and ECG, a Holter (to demonstrate PVC
burden) and echocardiogram is valuable.
Definitions of frequent PVCs vary: > 60/hr, > 1% of total QRS complexes, > 1000 per 24
hours
4. There is a new entity of “PVC-induced cardiomyopathy”
5. A cardiology referral should be considered for patients who are:
a) symptomatic, or;
b) if they have frequent PVCs, to delineate the best management
strategy for further serial evaluation
18. 5/25/14
18
The cardiologist determines that Mr. deMyse has “heart
pounding” palpitations that is non-arrhythmic in origin.
He has frequent PVCs, but these are asymptomatic. There
is no evidence of nonsustained ventricular tachycardia on
his Holter monitor reports.
Given that Mr. deMyse has hypertrophic cardiomyopathy, the
cardiologist decides to follow Mr. deMyse closely, and
informs him of possible symptoms that would warrant
urgent evaluation.
A followup visit is arranged for 3 month’s time.
Case 3. The case of Earl E. deMyse.
What is your next step?
a. Get a Holter
b. Get an event monitor
c. Reassure her, it’s vasovagal
d. Tell her to stop working
Case 4. The case of Terry Fyde.
You see Miss Fyde, a 26 year old, in your office.
She is an otherwise healthy lady who comes to your attention after having had a
syncopal spell.
On this occasion, she was at work at the counter of her university library. She
had missed her lunch and the room was full of students. She felt unwell,
lightheaded, and after a few minutes, proceeded to go to get a drink of water
but lost consciousness at the water cooler.
This type of scenario has occurred a few times before, and she has lost
consciousness all times, thankfully without much more than a bruised ego.
19. 5/25/14
19
Case 4. The case of Terry Fyde.
HOLTER REPORT
NAME: TERRY FYDE
DOB: 02/30/1986
REPORT:
Sinus rhythm throughout
Episodes of sinus slowing and junctional escape rhythm
One episode occurred during daytime hours, with associated “dizziness and nausea”, suggesting
intrinsic sinus node disease
IMPRESSION:
Sinus node dysfunction. Abnormal Holter.
A referral was made to have Terry see a cardiologist.
The cardiologist agreed that her symptoms were most likely
vasovagal. Further understudy of the Holter was taken.
Case 4. The case of Terry Fyde.
It turns out that she had both a Holter and lab work
requested. Her labs were drawn while Holter on. Being
terrified of needles, she felt vagal at the time of her needle
puncture. Her Holter was consistent with high vagal tone.
20. 5/25/14
20
Terry was reassured of the benign nature of her vasovagal
syncope and the reassuring Holter results.
She was advised of the conservative treatment measures
with regards to her vasovagal events.
She has continued working in the library and while a few
more episodes of “feeling unwell” have occurred, these are
self-limiting and she has not had any further syncope.
Case 4. The case of Terry Fyde.
Summary
1. Many people have palpitations.
2. An assessment of palpitations includes a detailed history,
physical examination, and ECG, to determine the
underlying risk of a possible sinister arrhythmia.
3. The need for further investigations, and the type of
ambulatory ECG monitoring, is aimed towards achieving
a definitive diagnosis and assessment of prognosis.
4. This depends on the frequency of symptoms, the need
for diagnosis, and the underlying perceived risk.
5. Remember that your friendly neighbourhood cardiologist
is always available!